Outcomes of monthly video consultations as an add-on to regular care for children with type 1 diabetes: A 6-month quasi-randomized clinical trial followed by an extension phase.
CGM
telemedicine
type 1 diabetes
video consultation
Journal
Pediatric diabetes
ISSN: 1399-5448
Titre abrégé: Pediatr Diabetes
Pays: Denmark
ID NLM: 100939345
Informations de publication
Date de publication:
12 2020
12 2020
Historique:
received:
02
06
2020
revised:
05
09
2020
accepted:
24
09
2020
pubmed:
4
10
2020
medline:
1
10
2021
entrez:
3
10
2020
Statut:
ppublish
Résumé
To explore the outcomes of monthly video consultations for children with diabetes. The Virtual Outpatient Diabetes Clinic for Children and Youth (VIDIKI) was a 6-month multicenter controlled clinical trial followed by an extension phase. The 240 participants (1-16 years), all using a CGM, were quasi-randomized by residence location to the intervention group (IG) or the waitlist-control group (WG). The IG started immediately after enrollment with monthly video consultations as an add-on to regular care, while the WG received regular care for 6 months before starting the intervention. The extension phase lasted between 12 months and 2 years, depending on the enrollment date. Linear regression was applied to model the primary outcome of HbA1c after 6 months and other metabolic and psychosocial outcomes. After covariate adjustments, the HbA1c at 6 months-corresponding to the controlled treatment phase-was 0.11% lower in the IG than that in the WG (95% CI -0.31 to 0.09, P = .277). For the total study sample, a significant HbA1c improvement was found after 12 months of video consultations, which increased further until month 15. The diabetes burden of the main caregivers was lower, and parental treatment satisfaction was significantly higher in the IG than that in the WG. The VIDIKI study found no significant HbA1c difference between IG and WG after 6 months in the controlled phase, but there was a decreased diabetes burden and increased treatment satisfaction for the parents. In the longitudinal perspective, a significant HbA1c improvement was found after 12 and 15 months.
Substances chimiques
Blood Glucose
0
Types de publication
Journal Article
Multicenter Study
Randomized Controlled Trial
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1502-1515Informations de copyright
© 2020 John Wiley & Sons A/S . Published by John Wiley & Sons Ltd.
Références
Danne T, Phillip M, Buckingham BA, et al. ISPAD clinical practice consensus guidelines 2018: insulin treatment in children and adolescents with diabetes. Pediatr Diabetes. 2018;19(Suppl 27):115-135.
Giani E, Laffel L. Opportunities and challenges of telemedicine: observations from the wild west in pediatric type 1 diabetes. Diabetes Technol Ther. 2016;18:1-3.
Tonyushkina KN, Cobb V, Moskovitz A, Allen HF. Televisits to partially substitute for clinic visits are feasible and well accepted by tech-savvy patients with T1DM and their families: a prospective pilot study. J Diabetes Sci Technol. 2018;12:1084-1085.
Reid MW, Krishnan S, Berget C, et al. CoYoT1 clinic: home telemedicine increases young adult engagement in diabetes care. Diabetes Technol Ther. 2018;20:370-379.
Frielitz FS, Muller-Godeffroy E, Hubner J, et al. Monthly video-consultation for children with type 1 diabetes using a continuous glucose monitoring system: design of ViDiKi, a multimethod intervention study to evaluate the benefit of telemedicine. J Diabetes Sci Technol. 2020; Jan;14(1):105-111.
The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin dependent diabetes mellitus. N Engl J Med. 1993;329:977-986.
Ravens-Sieberer U, Bullinger M. Assessing health-related quality of life in chronically ill children with the German KINDL: first psychometric and content analytical results. Qual Life Res. 1998;7(5):399-407.
Ravens-Sieberer U. Manual-kindl.org. kindl.org; 2019. Available from http://www.kindl.org/deutsch/manual/. Accessed April 15, 2019.
WHO. WHO-5 questionnaires; 2018. Available from https://www.psykiatri-regionh.dk/who-5/Pages/default.aspx. Accessed July 31, 2018.
Leonard BJ, Skay CL, Rheinberger MM. Self-management development in children and adolescents with diabetes: the role of maternal self-efficacy and conflict. J Pediatr Nurs. 1998;13:224-233.
Grossman HY, Brink S, Hauser ST. Self-efficacy in adolescent girls and boys with insulin-dependent diabetes mellitus. Diabetes Care. 1987;10:324-329.
Sethe D, Büssing A, Hilgard D, Berger B. Validation of the German version of pediatric self-efficacy for diabetes-type-1 scale. Psychother Psychosom Med Psychol. 2020;70(8):349-357. https://doi.org/10.1055/a-1088-1316.
Schwarzer R, Jerusalem M. Generalized self-efficacy scale. In: Weinman J, Wright S, Johnston M, eds. Measures in Health Psychology: A User's Portfolio Causal and Control Beliefs. Windsor, UK: NFER-NELSON; 1995:35-37.
Vickers AJ, Altman DG. Statistics notes: analysing controlled trials with baseline and follow up measurements. BMJ. 2001;323:1123-1124.
van Buuren S. Flexible Imputation of Missing Data. Boca Raton, FL: CRC Press; 2018.
R Core Team. R: a language and environment for statistical computing. R foundation for statistical computing; 2018. Available from https://www.r-project.org/. Accessed April 2, 2019.
Glickman ME, Rao SR, Schultz MR. False discovery rate control is a recommended alternative to Bonferroni-type adjustments in health studies. J Clin Epidemiol. 2014;67:850-857.
Ruiz de Adana MS, Alhambra-Expòsito MR, Munoz-Garach A, et al. Randomized study to evaluate the impact of telemedicine Care in Patients with type 1 diabetes with multiple doses of insulin and suboptimal HbA1c in Andalusia (Spain): PLATEDIAN study. Diabetes Care. 2020;43(2):337-342.
Fischer KI, Fischer FH, Barthel D, et al. Trajectories of health-related quality of life and HbA1c values of children and adolescents with diabetes mellitus type 1 over 6 months: a longitudinal observational study. Front Pediatr. 2020;7:566.
Marker AM, Monzon AD, Nelson EL, Clements MA, Patton SR. An intervention to reduce hypoglycemia fear in parents of young kids with type 1 diabetes through video-based telemedicine (REDCHiP): trial design, feasibility, and acceptability. Diabetes Technol Ther. 2020;1:25-33.
Crossen SS, Marcin JP, Qi L, et al. Home visits for children and adolescents with uncontrolled type 1 diabetes. Diabetes Technol Ther. 2020 Jan;22(1):34-41.
Bakhach M, Reid MW, Pyatak EA, et al. Home telemedicine (CoYoT1 clinic): a novel approach to improve psychosocial outcomes in young adults with diabetes. Diabetes Educ. 2019 Aug;45(4):420-430.
DeSalvo DJ, Miller KM, Hermann JM et al. Contionus glucose monitoring and glycemic control among youth with type 1 diabetes: International comparison from the T1D Exchange and DPV Initiative. Pediatric Diabetes. 2018;19:1271-1275.
Hermann JM, Miller KM, Hofer SE, et al. The transatlantic HbA1c gap: differences in glycaemic control across the lifespan between people included in the US T1D Exchange Registry and those included in the German/Austrian DPV registry. Diabet Med. 2020;37(5):848-855. https://doi.org/10.1111/dme.14148.
Foster NC, Beck RW, Miller KM, et al. State of type 1 diabetes management and outcome from the T1 D exchange in 2017-2018. Diabetes Technol Ther. 2019;21(2):66-72.
Gandrud L, Altan A, Buzinec P, et al. Intensive remote monitoring versus conventional care in type 1 diabetes: a randomized controlled trial. Pediatr Diabetes. 2018;19:1086-1093.
Frielitz FS, Dördelmann J, Lemke S, et al. Assessing the benefits and challenges of video consultations for the treatment of children with type 1 diabetes-a qualitative study among diabetes professionals. Exp Clin Endocrinol Diabetes. 2020;22(8):623-638. https://doi.org/10.1055/a-1149-8814.
De Guzman KR, Snoswell CL, Taylor ML, et al. A systematic review of paediatric telediabetes service models. Diabetes Technol Ther. 2020;22:623-638. https://doi.org/10.1089/dia.2019.0489.